Consensus $14.56. Narrows FY24 revenue view to 6.6%-7.7% from 6.4%-7.5%. The company said, “Labcorp (LH) is updating 2024 full year guidance to reflect its third quarter performance and full year outlook. The following guidance assumes foreign exchange rates effective as of September 30, 2024, for the remainder of the year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Notable companies reporting before tomorrow’s open
- Activist Corvex acquires stake in Fortrea Holdings, Bloomberg reports
- Laboratory Corporation Of America (LH) Q3 Earnings Cheat Sheet
- Labcorp named exclusive distributor of First To Know Syphilis Test
- Labcorp price target lowered to $234 from $249 at Barclays